VKTX - Viking Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

VKTX is currently covered by 6 analysts with an average potential upside of $8.83 (93.5%) backed by displayed 27 price targets and 48 ratings.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 69.15% with an average time for these price targets to be met of 395.83 days.

Highest price target for VKTX is 25, Lowest price target is 2, average price target is 13.5.

Most recent stock forecast was given by ANNABEL SAMIMY from STIFEL on 08-Aug-2023. First documented stock forecast 21-Nov-2017.

Currently, out of the existing stock ratings of VKTX - 21 which are a Buy (100%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

30

$18.93 (171.00%)

30

1 months 22 days ago

1/4 (25%)

$10.22 (70.14%)

45

Buy

32

$20.93 (189.07%)

32

3 months 3 days ago

0/2 (0%)

$16.62 (108.26%)

Buy

37

$25.93 (234.24%)

35

4 months 13 days ago

5/7 (71.43%)

$8.29 (95.91%)

243

Buy

40

$28.93 (261.34%)

30

4 months 14 days ago

1/3 (33.33%)

$12.82 (77.08%)

54

Buy

36

$24.93 (225.20%)

31

4 months 14 days ago

1/3 (33.33%)

$13.14 (108.92%)

120

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VKTX (Viking Therapeutics) average time for price targets to be met?

On average it took 395.83 days on average for the stock forecasts to be realized with a an average price target met ratio 69.15

Which analyst has the current highest performing score on VKTX (Viking Therapeutics) with a proven track record?

MICHAEL MORABITO

Which analyst has the most public recommendations on VKTX (Viking Therapeutics)?

Michael Morabito works at CHARDAN CAPITAL and has 4 price targets and 4 ratings on VKTX

Which analyst is the currently most bullish on VKTX (Viking Therapeutics)?

Jay Olson with highest potential upside - $28.93

Which analyst is the currently most reserved on VKTX (Viking Therapeutics)?

Jason Mccarthy with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart